Access

News

Nature 415, 462 (31 January 2002) | doi:10.1038/415462a

Open Innovation Challenges

naturejobs

Nerve inflammation halts trial for Alzheimer's drug

Erika Check

Trials of a new immunotherapy drug for Alzheimer's disease have hit a roadblock, with four of the participants developing potentially serious problems in the nervous system. Some researchers say the side-effect could have been anticipated before the trial began.